On behalf of an established Alacrita client, a publicly traded clinical stage biotechnology company with a cell therapy platform technology, we assessed the potential of a novel extracellular vesicle technology across a range of potential applications. The technology, which had been developed in-house, was based on vesicles produced from stem cells. The client asked Alacrita to assess the competitiveness of its technology and, if appropriate, to develop a strategy based on selected applications/disease indications.


Alacrita assembled a multidisciplinary team to conduct a phased work-plan involving:

  • Identification of sustainable differentiators within the extracellular vesicle landscape
  • Generating a long list of strategic options and associated product opportunities
  • Triaging, characterizing and prioritizing the potential opportunities based on a combination of commercial attractiveness and technology fit
  • Synthesize the conclusions into an actionable strategy.
Through a series of workshop meetings with the client team, we developed a consensus which the client team presented to it Board.

Opportunity Mapping Services

We can help you gauge and rank the opportunities for your R&D programs or technology platforms to deliver value, by framing the commercial potential and charting the path to market.

Contact Us

Reach out today for more information on our opportunity mapping expertise.

Related Case Studies | View all